Fact-checked by Grok 2 weeks ago

Innate immune system

The innate immune system is the body's first line of defense against pathogens, providing rapid, nonspecific responses to infection through pre-existing mechanisms encoded in genes, without the need for prior exposure. It encompasses physical barriers, soluble mediators, and cellular components that recognize conserved molecular patterns on microbes, such as pathogen-associated molecular patterns (PAMPs), to prevent invasion and eliminate threats within minutes to hours. Unlike the , which develops specificity and memory over days, the innate system traditionally lacks immunological memory but plays a crucial role in initiating and shaping adaptive responses by alerting and recruiting specialized cells. Although traditionally viewed as lacking memory, recent studies have identified "trained immunity," a form of epigenetic reprogramming in innate immune cells that provides enhanced, non-specific protection upon re-exposure. Key components of the innate immune system include epithelial barriers like and mucosal surfaces, which form the initial physical shield against microbial entry, often reinforced by such as and cilia that trap and expel invaders. Cellular effectors, including (neutrophils and macrophages) that engulf and destroy pathogens via , natural killer () cells that target virus-infected or stressed cells, and , provide active elimination and cytokine-mediated signaling to amplify . Soluble factors, such as the —a of over 20 proteins that promotes opsonization, , and —and acute-phase proteins like , further enhance pathogen clearance and recruit immune cells to infection sites. Recognition in the innate immune system relies on receptors (PRRs), including Toll-like receptors (TLRs) on surfaces and endosomes that detect bacterial lipopolysaccharides or nucleic acids, as well as intracellular NOD-like receptors (NLRs) that sense cytosolic threats. These receptors trigger signaling pathways leading to the production of proinflammatory cytokines, type I interferons, and antimicrobial responses, while also distinguishing self from non-self to avoid . Dysregulation of innate immunity can contribute to chronic , autoimmune diseases, or heightened susceptibility to infections, as seen in deficiencies like mannose-binding lectin (MBL) variants affecting 5–30% of populations. Overall, this ancient system, conserved across multicellular organisms, ensures immediate protection and , bridging innate and adaptive immunity for comprehensive host defense.

Overview and Fundamentals

Definition and Key Features

The innate immune system constitutes the first line of defense in multicellular organisms, providing an immediate and non-specific response to invading through germline-encoded mechanisms that do not require prior exposure or sensitization. This system activates rapidly, often within minutes to hours of pathogen encounter, enabling quick containment of infections before they escalate. Its responses target broad pathogen-associated molecular patterns (PAMPs), which are conserved molecular structures common to large groups of microbes, such as components of bacterial cell walls, allowing without the need for antigen-specific . Key features of innate immunity include its non-specificity, which contrasts with more tailored defenses, and its classical lack of immunological memory, meaning responses do not improve or accelerate upon re-exposure to the same . However, recent has identified "trained immunity," an epigenetic reprogramming of innate immune cells like monocytes and macrophages that leads to enhanced non-specific responses to subsequent s, challenging the traditional view of no memory. Beyond pathogen defense, the innate immune system contributes to tissue homeostasis by regulating and maintaining physiological balance in the absence of , such as through of cellular and of repair processes. These attributes ensure a foundational layer of protection that operates continuously from birth. Evolutionarily, innate immunity is ancient and conserved, present in all multicellular organisms from to vertebrates, and predates the emergence of adaptive immunity by hundreds of millions of years. Its historical recognition traces back to the , when Élie Metchnikoff's studies on cellular responses to laid the groundwork for understanding innate defense mechanisms. In vertebrates, innate immunity also serves as a bridge to adaptive responses by providing initial signals that activate and shape long-term immunity.

Distinction from Adaptive Immunity

The innate immune system differs fundamentally from the in its pre-formed, non-clonal nature, relying on germline-encoded receptors that recognize broad pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharides on , without the need for or clonal expansion. In contrast, the generates antigen-specific responses through the somatic rearrangement of (TCR) and (BCR) genes, leading to the proliferation of clones tailored to particular epitopes. This distinction ensures the innate system's immediate, non-specific against a wide array of pathogens, while the achieves high specificity but requires time for development. Traditionally, a key contrast lies in the lack of immunological in the innate immune system, where responses do not improve or accelerate upon re-exposure to the same , unlike the adaptive system's memory cells that enable rapid, enhanced protection in secondary encounters. However, emerging evidence of trained immunity shows that innate immune cells can undergo epigenetic changes leading to heightened, non-specific responses upon re-challenge, providing a form of adaptive plasticity distinct from adaptive . Additionally, innate receptors lack mechanisms like , which the adaptive system employs to refine antibody , further underscoring the innate system's fixed, evolutionarily conserved recognition capabilities. Temporally, the innate immune system provides the first line of , activating within hours to contain infections and limit spread, thereby buying time for the slower adaptive response, which typically peaks after several days through clonal expansion. This rapid onset of innate immunity is crucial for initial control, as delays in adaptive activation could prove fatal. Despite these differences, the two systems exhibit significant overlap, with the innate immune system priming the adaptive response through by cells like dendritic cells and the secretion of cytokines that direct T- and B-cell differentiation. For instance, innate recognition of PAMPs via Toll-like receptors triggers signals that enhance adaptive immunity, illustrating their complementary roles in orchestrating a coordinated .

Physical and Chemical Barriers

Anatomical Barriers

The innate immune system's anatomical barriers serve as the primary line of defense by forming passive physical structures that impede the entry of pathogens into the body. These barriers, including and mucosal linings, exploit mechanical and structural properties to block microbial invasion without relying on active immune responses. Their effectiveness stems from continuous renewal and coordinated physiological processes that expel potential threats before they can establish infection. The skin represents the largest and most robust anatomical barrier, consisting of a multilayered keratinized epithelium that provides a tough, impermeable shield against environmental pathogens. The outermost stratum corneum, composed of dead keratinocytes filled with keratin, creates a dry, acidic surface that desiccates and mechanically resists penetration by microbes. Tight junctions between viable epithelial cells in the underlying layers further seal intercellular spaces, preventing paracellular entry of bacteria and viruses. Additionally, the process of desquamation—continuous shedding of the superficial skin layer—physically removes adherent pathogens, ensuring the barrier's renewal. Mucosal surfaces line the body's internal cavities exposed to the external environment, such as the respiratory, gastrointestinal, and urogenital tracts, where they form a dynamic yet passive barrier through viscous mucus layers secreted by goblet cells and submucosal glands. In the respiratory tract, this mucus coats the epithelium, trapping inhaled microbes and particulates in a gel-like matrix that adheres to pathogens via electrostatic and hydrophobic interactions. Similar mucus barriers in the gastrointestinal tract ensnare ingested bacteria, while in the urogenital system, cervical and urethral mucus hinders ascent of pathogens toward internal organs. These surfaces are particularly vulnerable due to their moist environment but maintain integrity through rapid epithelial turnover and selective permeability. Beyond the skin and mucosa, specialized structures enhance mechanical clearance in specific regions. In the airways, ciliated epithelial cells propel the mucus layer upward via coordinated beating at 10–20 Hz, facilitating that sweeps trapped microbes toward the for expulsion through coughing or . The eyes and oral cavity benefit from constant flushing by and , respectively; lacrimal glands produce a thin fluid film that washes away ocular contaminants, while salivary flow from major glands like the parotid mechanically dislodges oral at rates sufficient to clear most debris within minutes. These flushing mechanisms collectively minimize pathogen adhesion and proliferation on exposed surfaces. Mechanical propulsion further bolsters these barriers in the digestive and urinary systems. Peristaltic contractions in the generate wave-like movements that propel contents, including trapped microbes, through the toward elimination, with transit times varying from hours in the to days in the colon. In the urinary tract, continuous flow from glomerular filtration—averaging 1–2 liters daily in adults—flushes the and , diluting and expelling any ascending before they can colonize the . These processes ensure that even if pathogens breach initial traps, they are rapidly removed from vulnerable sites.

Soluble and Secretory Defenses

The innate immune system's soluble and secretory defenses encompass a range of biochemical factors secreted at mucosal and epithelial surfaces to inhibit microbial invasion, colonization, and proliferation. These components, produced constitutively or in response to microbial cues, include , enzymes, and environmental modulators that disrupt integrity or deprive them of essential nutrients, thereby complementing physical barriers like that trap microbes for expulsion. Antimicrobial peptides, such as and cathelicidins, are key effectors in these defenses, forming amphipathic structures that insert into and permeabilize bacterial membranes, leading to cell lysis. Alpha-defensins, produced by neutrophils and Paneth cells in the gut, exhibit broad-spectrum activity against Gram-positive and , while beta-defensins are secreted by epithelial cells at , respiratory, and gastrointestinal sites. Cathelicidins, exemplified by human LL-37, are processed from propeptides and similarly target microbial membranes while modulating to prevent excessive tissue damage. Enzymatic secretions further bolster these barriers; lysozyme, abundant in tears, saliva, and nasal secretions, hydrolyzes the beta-1,4 glycosidic bonds in peptidoglycan, the cell wall component of many bacteria, thereby causing osmotic lysis. Complementing this, lactoferrin, found in mucosal secretions like milk, saliva, and tears, binds free iron with high affinity, sequestering it from iron-dependent pathogens and inhibiting their growth while also exerting direct membrane-disrupting effects. Environmental factors at barrier sites provide additional chemical inhibition; the stomach's acidic milieu, maintained at a pH of 1-3 by from parietal cells, denatures microbial proteins and enzymes, effectively sterilizing ingested pathogens. In the intestine, bile salts secreted by the liver into the emulsify fats but also possess detergent-like properties that solubilize bacterial membranes, reducing microbial viability and aiding in the clearance of lipid-enveloped viruses. Secretory immunoglobulin A (sIgA), while primarily adaptive, includes an innate-like component through T-cell-independent production by cells in mucosal tissues, where it coats luminal microbes to prevent epithelial adherence without triggering . This non-specific sIgA contributes to baseline mucosal , particularly in the gut and .

Cellular Effectors

Phagocytic Cells

Phagocytic cells are central effectors of the innate immune system, specializing in the recognition, engulfment, and destruction of pathogens and damaged cells. These professional phagocytes include macrophages, which reside in tissues and derive from circulating monocytes; neutrophils, the most abundant circulating leukocytes that rapidly respond to infection sites; and dendritic cells, which primarily capture antigens for presentation while also contributing to . Macrophages and neutrophils are highly efficient at eliminating microbes, whereas dendritic cells focus more on bridging innate and adaptive responses through . The process begins with recognition of pathogens through opsonins such as complement proteins (C3b) and collectins like -binding lectin (MBL), which bind to microbial surfaces and engage complement or receptors on , or directly via pathogen-associated molecular patterns (PAMPs) recognized by receptors. This triggers actin cytoskeleton remodeling, leading to pseudopod extension around the target and its engulfment into a membrane-bound . The then matures by fusing with lysosomes and endosomes, forming a phagolysosome with an acidic (pH approximately 4.5-5.0) enriched in hydrolytic enzymes, , and reactive species that degrade the engulfed material. Once internalized, killing mechanisms activate to neutralize pathogens. A primary method involves the generation of (ROS) through the NADPH oxidase complex, which assembles on the phagosomal membrane to produce anions (O₂⁻) that convert to hydrogen peroxide (H₂O₂) and other oxidants, damaging microbial proteins, lipids, and DNA. In addition, , particularly macrophages, produce nitric oxide (NO) via inducible (iNOS), which reacts with to form (ONOO⁻), a potent antimicrobial agent that disrupts pathogen membranes and enzymes. These oxidative bursts are tightly regulated to prevent host tissue damage. Recruitment of phagocytic cells to infection sites occurs primarily through , guided by gradients of such as interleukin-8 (IL-8, also known as CXCL8), which is secreted by infected tissues and attracts neutrophils via specific G-protein-coupled receptors. Macrophages and dendritic cells respond to similar signals, including other like , ensuring rapid mobilization from blood or resident pools to the site of microbial invasion. This coordinated migration enhances the efficiency of the innate response.

Non-Phagocytic Leukocytes

Non-phagocytic leukocytes in the innate immune system contribute to host defense through mechanisms involving direct , granule release, and rapid cytotoxicity, distinct from engulfment-based processes. These cells, including mast cells, , , natural killer (NK) cells, and γδ T cells, respond swiftly to pathogens and stressed cells by secreting bioactive mediators or inducing , thereby bridging innate responses and amplifying . Mast cells are tissue-resident granulocytes that play a key role in innate immunity by undergoing upon activation by pathogen-associated molecular patterns or parasite products, releasing and other vasoactive amines to promote localized and . This facilitates the recruitment of additional immune cells to sites and enhances parasite expulsion, particularly against helminths, where mast cell-derived mediators like and chymase contribute to tissue remodeling and defense. Although mast cells are implicated in allergic responses through IgE-mediated activation, their innate functions in parasite control underscore their evolutionary role in host protection independent of adaptive immunity. Basophils and eosinophils, circulating granulocytes, further support innate defense against multicellular parasites, such as helminths, through targeted exocytosis. Basophils release upon IgE crosslinking or direct parasite stimulation, amplifying type 2 inflammatory responses and promoting eosinophil recruitment to infected tissues. Eosinophils, in turn, deploy major basic protein (MBP)—a cationic protein comprising over 50% of their core—from their crystalloid granules to disrupt helminth teguments via direct toxicity, impairing parasite motility and viability. This eosinophil-mediated is particularly effective against larval stages of nematodes, where MBP induces membrane damage without requiring involvement in early innate phases. Natural killer (NK) cells, large granular lymphocytes of the innate lymphoid lineage, execute against virus-infected or transformed cells through two primary mechanisms: (ADCC) and granule-mediated . In ADCC, NK cells bind IgG-opsonized targets via the receptor, triggering that releases perforin to form pores in the target membrane, allowing granzyme entry to activate caspase cascades and induce . Independently of antibodies, NK cells recognize stressed cells lacking expression and deploy perforin/granzyme pathways to lyse targets, thereby providing an early barrier against intracellular pathogens like viruses. This rapid, non-specific killing preserves host integrity during the initial hours of infection. Beyond NK cells, other (ILCs), including ILC1, ILC2, and ILC3, contribute to innate defense at mucosal and barrier sites. ILC1s produce interferon-gamma (IFN-γ) to combat intracellular pathogens, ILC2s secrete interleukin-5 (IL-5) and IL-13 to promote type 2 immunity against helminths and allergens, and ILC3s produce IL-17 and to defend against extracellular bacteria and fungi while maintaining tissue homeostasis. γδ T cells, a subset of T lymphocytes expressing a heterodimeric , function as innate-like effectors by recognizing non-MHC ligands on stressed or infected cells, enabling early surveillance without classical . These cells detect phosphoantigens, , or stress-induced molecules such as MICA/MICB via germline-encoded receptor regions, leading to production (e.g., IFN-γ) and through perforin/granzyme release. This MHC-unrestricted recognition positions γδ T cells at the interface of innate and adaptive immunity, where they rapidly respond to epithelial threats like bacterial or fungal invaders, promoting tissue and clearance.

Molecular Recognition and Effector Pathways

Pattern Recognition Receptors

Pattern recognition receptors (PRRs) are a class of germline-encoded proteins expressed by innate immune cells that detect conserved molecular structures known as pathogen-associated molecular patterns (PAMPs) derived from microbes, as well as damage-associated molecular patterns (DAMPs) from host cells under stress or . These receptors enable rapid recognition of potential threats without prior exposure, distinguishing the innate immune system from adaptive responses. PRRs are strategically localized on cell surfaces, within endosomes, or in the to monitor different compartments for invading pathogens. The Toll-like receptors (TLRs) represent one major family of PRRs, with 10 members in humans divided into those on the plasma membrane (e.g., TLR1, TLR2, , TLR5, TLR6) and those in endosomal compartments (e.g., TLR3, TLR7, TLR8, TLR9). Surface TLRs primarily recognize extracellular bacterial components, such as (LPS) from via TLR4 or from bacterial flagella via TLR5, while endosomal TLRs detect nucleic acids like double-stranded RNA (TLR3) or unmethylated CpG DNA (TLR9) from viruses and bacteria. Another key family, the NOD-like receptors (NLRs), operates in the and includes about 22 members in humans, such as NOD1 and , which sense intracellular fragments from bacterial cell walls. Additional PRR families expand detection capabilities to specific pathogen classes. RIG-I-like receptors (RLRs), including RIG-I and , are cytosolic sensors that identify viral RNAs, such as short double-stranded RNAs with 5'-triphosphate ends (RIG-I) or longer double-stranded RNAs (). C-type lectin receptors (CLRs), such as Dectin-1 and Dectin-2, are predominantly surface receptors that bind carbohydrate structures on fungal cell walls, including β-1,3-glucans. Upon ligand binding, PRRs initiate signaling cascades that amplify immune responses. Most TLRs employ a MyD88-dependent pathway, recruiting adaptor proteins to activate kinases like IRAK and TRAF6, ultimately leading to nuclear translocation of and transcription of proinflammatory genes. NLRs and RLRs similarly converge on or IRF3/7 pathways, promoting cytokine production and inflammasome assembly for IL-1β maturation. CLRs often signal through Syk kinase to induce or MAPK activation. These receptors bridge pathogen detection to effector functions, triggering inflammation through cytokine release and enhancing phagocytosis by upregulating opsonins and phagocytic receptors on immune cells. By initiating these processes, PRRs provide the first line of defense and set the stage for broader innate responses, including complement activation.

Complement System

The complement system is a critical humoral component of the innate immune response, comprising over 30 soluble and cell-bound proteins that form a proteolytic cascade to detect, tag, and eliminate pathogens. This system amplifies innate defenses by promoting opsonization, inflammation, and direct lysis of microbes, while being tightly regulated to prevent damage to host tissues. Activation occurs through three main pathways—classical, alternative, and lectin—all converging on the central C3 component to generate effector functions. The classical pathway is initiated when C1q, a recognition subunit of the C1 complex, binds directly to pathogen-associated molecular patterns (PAMPs) on microbial surfaces or to antibody-antigen complexes, though the innate trigger via C1q-PAMPs predominates in early responses. This binding activates C1r and C1s serine proteases, which cleave C4 and C2 to form the C3 convertase C4b2a. The alternative pathway operates independently of antibodies, beginning with the spontaneous hydrolysis of C3 in plasma to form C3(H2O), which binds factor B; factor D then cleaves factor B to generate the initial C3 convertase C3bBb, which is stabilized by properdin and amplified on pathogen surfaces lacking host regulators. The lectin pathway, involving pattern recognition receptors such as mannose-binding lectin (MBL), is triggered by MBL or ficolins recognizing carbohydrate motifs on pathogens; associated MBL-associated serine proteases (MASPs), particularly MASP-2, cleave C4 and C2 to produce the same C3 convertase C4b2a as in the classical pathway. Central to all pathways is the , which cleaves into C3a (an anaphylatoxin) and C3b, the latter depositing covalently on surfaces to facilitate opsonization and mark targets for clearance. C3b deposition leads to formation of C5 convertases (C4b2a3b or C3bBb3b), which cleave into C5a and C5b; C5b initiates the terminal pathway by sequentially recruiting C6, C7, C8, and multiple C9 molecules to assemble the membrane attack complex (MAC), C5b-9, a pore-forming structure that lyses susceptible microbes by disrupting their membranes. To avert autologous injury, the complement system is regulated by soluble and membrane-bound inhibitors; for instance, C1 esterase inhibitor (C1-INH) dissociates and inactivates C1r and C1s in the classical pathway, as well as MASPs in the , while factors such as H and I degrade C3b on host cells. Outcomes of activation include enhanced pathogen elimination through opsonization and lysis, alongside phagocyte recruitment mediated by C5a, a potent chemoattractant that draws neutrophils and monocytes to sites, thereby bridging to cellular innate responses.

Inflammatory Mediators

Inflammatory mediators are soluble signaling molecules released by innate immune cells and tissues in response to or , coordinating local inflammatory responses through changes, leukocyte recruitment, and systemic effects. These mediators amplify the innate immune reaction by promoting endothelial activation, , and , thereby facilitating the influx of to the site of pathogen invasion. Key classes include cytokines, , acute-phase proteins, and vasoactive amines, which collectively orchestrate the transition from detection to effector functions in the innate immune system. Cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) are pivotal pro-inflammatory mediators produced primarily by macrophages and endothelial cells upon recognition of pathogen-associated molecular patterns (PAMPs). IL-1, released in two forms (IL-1α and IL-1β), induces fever by acting on the and activates endothelial cells to express adhesion molecules like and , enabling leukocyte adhesion and . Similarly, TNF-α triggers by promoting endothelial permeability and synergizing with IL-1 to induce the expression of , thereby amplifying the local response. These cytokines are essential for the rapid escalation of innate defenses but can contribute to tissue damage if unchecked. Chemokines, a subset of cytokines, direct the migration of immune cells to inflammatory sites; for instance, CXCL8 (also known as IL-8) is a potent chemoattractant secreted by macrophages and epithelial cells, specifically recruiting neutrophils via interaction with CXCR1 and CXCR2 receptors on their surface. This enhances at foci, with CXCL8 levels rising dramatically during bacterial to guide swarms. Other like CCL2 complement this by attracting monocytes, ensuring a coordinated cellular influx. The acute-phase response represents a systemic arm of innate immunity, triggered by IL-1, IL-6, and TNF-α, leading to hepatic synthesis and release of proteins such as (CRP) and (SAP). CRP, a pentraxin family member, binds on bacterial surfaces and PAMPs, activating the and opsonizing pathogens for by macrophages. SAP similarly recognizes microbial carbohydrates, promoting clearance while modulating to prevent excessive damage; both proteins surge within hours of , providing an early humoral . Complement-derived anaphylatoxins like C3a and C5a further enhance this by inducing and vascular changes. Vasoactive mediators, including and , drive immediate vascular alterations to support . , released from mast cells and upon innate activation, binds H1 receptors on endothelial cells, causing rapid and increased permeability that allows proteins and cells to enter tissues. , generated via the kinin system from cleavage, acts on B2 receptors to similarly enhance permeability and signaling, facilitating immune cell access while contributing to formation at sites. These mediators ensure efficient delivery of effectors but require tight regulation to avoid . Resolution of inflammation is mediated by anti-inflammatory cytokines like IL-10, produced by regulatory T cells, macrophages, and dendritic cells to dampen pro-inflammatory signals and promote tissue repair. IL-10 inhibits the production of IL-1, TNF-α, and by suppressing signaling in innate cells, thereby limiting excessive influx and preventing chronic . This cytokine also enhances , the clearance of apoptotic cells, ensuring after pathogen elimination. Dysregulated IL-10 can impair defenses, underscoring its role in balancing innate responses.

Regulatory Mechanisms

Neural and Hormonal Control

The innate immune system is modulated by the through the cholinergic anti-inflammatory pathway, primarily mediated by the . This efferent pathway involves the release of from vagal nerve terminals, which binds to nicotinic acetylcholine receptors (α7nAChR) on macrophages and other innate immune cells, thereby inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This reflex serves as a systemic brake on excessive , preventing damage during or while maintaining immune vigilance. Hormonal regulation further integrates innate responses via the endocrine system, with glucocorticoids like exerting potent anti-inflammatory effects. , released from the , suppresses innate immunity by inhibiting the activation of macrophages and neutrophils, reducing secretion, and downregulating molecules on endothelial cells, which limits leukocyte to sites of . In contrast, catecholamines such as epinephrine and norepinephrine, secreted during acute , enhance innate defenses by promoting the rapid mobilization of neutrophils from reserves and increasing their phagocytic activity through β-adrenergic receptor signaling. Neuro-immune crosstalk occurs bidirectionally, with sensory neurons detecting inflammatory signals like s and responding by releasing neuropeptides. For instance, released from sensory nerve endings amplifies innate responses by stimulating degranulation and enhancing production from macrophages, thereby promoting local inflammation and immune cell recruitment. This interaction ensures coordinated responses but can escalate inflammation if dysregulated. A key example of systemic integration is stress-induced via the hypothalamic-pituitary-adrenal () axis, where chronic stress activates corticotropin-releasing hormone release, leading to elevated levels that broadly dampen innate immune functions, including reduced activity and impaired . This mechanism protects against overzealous immune activation during prolonged stress but increases susceptibility to infections.

Feedback and Tolerance

The innate immune system employs intricate feedback mechanisms to restrain excessive activation, thereby mitigating potential tissue damage and averting . These regulatory processes ensure a balanced response to threats while maintaining , particularly in environments rich with microbial signals. Negative regulators play a pivotal role in dampening signaling cascades, such as soluble (PRR) s that sequester ligands and prevent their interaction with cell-surface receptors. For instance, soluble (sTLR2) acts as a by binding bacterial lipoproteins and fungal components, thereby inhibiting downstream inflammatory signaling through membrane-bound TLR2. Similarly, intracellular inhibitors like A20 (also known as TNFAIP3) function as a ubiquitin-editing that deubiquitinates key intermediaries in the pathway, terminating and promoting the degradation of signaling complexes to limit pro-inflammatory production. Tolerance induction represents another critical feedback loop, exemplified by endotoxin tolerance, where prior exposure to (LPS) reprograms innate immune cells to hyporespond to subsequent challenges. This phenomenon primarily involves the downregulation of TLR4 expression on macrophages and other myeloid cells, coupled with epigenetic modifications that suppress activation and reduce production of cytokines like TNF-α and IL-6. Such tolerance prevents during repeated Gram-negative bacterial encounters but can also contribute to in chronic inflammatory states. Complementing this, apoptotic cell clearance by occurs in a non-inflammatory manner, facilitated by "eat-me" signals such as exposure on dying cells, which engage receptors like TIM-4 and MerTK on to trigger anti-inflammatory pathways, including the release of TGF-β and IL-10, without eliciting pro-inflammatory responses. In homeostatic contexts, the gut microbiota educates innate immune cells to tolerate commensal organisms, fostering non-responsiveness to benign microbial antigens. This education process involves continuous low-level stimulation through PRRs, which tunes the responsiveness of dendritic cells and macrophages via mechanisms like IRAK-M upregulation, an inhibitor of TLR signaling that biases responses toward tolerance rather than inflammation. Disruption of this microbiota-innate immune crosstalk, as seen in germ-free models, leads to heightened inflammatory readiness, underscoring its role in preventing aberrant activation against harmless .

Pathogen Counterstrategies

General Evasion Tactics

Pathogens employ a variety of general strategies to evade the innate immune system, primarily by interfering with (PAMP) recognition, disrupting effector mechanisms, and modulating host immune responses. These tactics allow and fungi to persist within the host, avoiding rapid clearance by and soluble factors like complement. Such evasion is crucial for establishing , as the innate immune system provides the first line of defense through conserved receptors and rapid responses. One key approach to blocking recognition involves surface modifications that mask PAMPs from receptors (PRRs). For instance, many bacterial species, such as , produce capsular that sterically hinder access to underlying PAMPs like lipoteichoic acid, thereby preventing activation of Toll-like receptors (TLRs) and subsequent complement deposition or . Similarly, molecular enables pathogens to resemble host structures, reducing immune detection; Neisseria meningitidis uses Opa proteins that mimic human CD66 receptors, allowing adhesion to host cells while evading PRR-mediated recognition. These mechanisms exploit the specificity of innate receptors, which are evolved to detect non-host patterns but can be fooled by structural similarity. Pathogens also inhibit innate effectors directly to neutralize antimicrobial activities. Bacterial proteases, such as those produced by Staphylococcus aureus (e.g., aureolysin and V8 protease), cleave complement components like C3 and C5, disrupting opsonization and membrane attack complex formation essential for lysis and phagocytosis. Biofilms further enhance resistance to phagocytosis; in Pseudomonas aeruginosa, the extracellular polymeric matrix shields bacteria from neutrophil engulfment and oxidative bursts, promoting chronic infections like those in cystic fibrosis lungs. These strategies not only impair immediate killing but also limit inflammation propagation. Immune modulation represents another broad tactic, where pathogens alter host signaling to dampen responses. Certain bacterial toxins suppress production; for example, Yersinia's YopJ acetylates MAP kinase kinases, inhibiting activation and reducing pro-inflammatory s like TNF-α and IL-6 from macrophages. Additionally, intracellular survival within allows evasion of extracellular defenses; Salmonella enterica serovar Typhimurium uses its (SPI-2) to modify the Salmonella-containing vacuole, resisting lysosomal fusion and while replicating inside macrophages. This subversion turns into reservoirs for dissemination. This ongoing pits adaptability against the conserved nature of innate receptors. evolve rapidly through mutations and , such as Salmonella modifying to evade TLR4 sensing, while host PRRs remain relatively static to ensure broad protection. Seminal studies highlight how this dynamic drives diversity, with high mutation rates in surface antigens outpacing innate immune evolution, fostering persistent threats like antibiotic-resistant strains.

Virus-Specific Mechanisms

Viruses have evolved sophisticated strategies to counteract the host's innate immune system, particularly by targeting signaling, pathways, and activation, allowing persistent replication and dissemination. These mechanisms are distinct from those employed by , focusing on intracellular exploitation during viral life cycles. For instance, viral proteins often directly interfere with key transcription factors like to suppress type I production, a of antiviral defense. One prominent example of interferon evasion involves the non-structural protein 1 (NSP1) of , which inhibits the activation of regulatory factor (IRF3) by blocking its , thereby preventing downstream of type I interferons during early infection. This suppression occurs in a dose-dependent manner, allowing the to replicate efficiently before the host mounts a robust response. Similarly, the HIV-1 transactivator of transcription (Tat) protein inhibits the transcriptional activity of nuclear factor-κB () in human monocytes by promoting deacetylation of the p65 subunit via SIRT1 recruitment, dampening -dependent expression of proinflammatory cytokines and antiviral genes essential for innate immunity. In addition to interferon pathway disruption, viruses block host cell apoptosis to evade elimination by natural killer (NK) cells. The adenovirus E1B 19K protein, a functional homolog of the cellular anti-apoptotic , prevents NK-mediated cell death by inhibiting Fas ligand-induced through disruption of the FADD-caspase-8 signaling complex in the extrinsic pathway. This blockade protects infected cells from perforin/granzyme and death receptor-mediated , enabling prolonged viral production and spread within the host. Herpesviruses further exemplify evasion through molecular mimicry, encoding viral interferon regulatory factors (vIRFs) that structurally and functionally resemble host IRFs to subvert innate signaling. In (KSHV), vIRF1 binds to and IRF7, recruiting cellular repressors to inhibit their transcriptional activity and block type I promoter activation, while also interfering with pathways. These vIRFs, including vIRF2-4, collectively antagonize multiple arms of innate immunity, such as JAK-STAT signaling, to maintain viral and reactivation. Recent studies on SARS-CoV-2 variants highlight ongoing evolution in innate immune evasion. The Delta variant potently suppresses innate immune responses, including interferon production and IRF3 activation, more effectively than ancestral strains. Similarly, Omicron variants may diminish TLR signaling efficiency through spike protein mutations that alter charge distribution, potentially leading to weaker NF-κB activation and contributing to higher transmissibility observed post-2020. As of 2025, subsequent variants like those in the JN and XBB lineages continue to evolve spike mutations that enhance evasion of innate immune sensing, including TLR and interferon pathways, contributing to persistent circulation. These adaptations underscore the dynamic interplay between viral evolution and host innate defenses.

Comparative Innate Immunity

In Prokaryotes

Prokaryotes, primarily and , lack the complex cellular and humoral components of eukaryotic innate immunity but possess analogous molecular defense mechanisms that provide rapid, non-specific protection against invading genetic elements such as bacteriophages and plasmids. These systems function as innate barriers by recognizing foreign DNA or coordinating cellular responses to limit replication of invaders, often at the cost of the infected cell or through population-level strategies. Key examples include restriction-modification () systems, toxin-antitoxin () modules, and quorum sensing-mediated coordination, with the CRISPR-Cas system representing a hybrid that incorporates adaptive elements into an otherwise innate framework. These defenses highlight the evolutionary pressures driving prokaryotic survival in phage-rich environments, where and viral predation are constant threats. Restriction-modification systems serve as a primary innate defense in prokaryotes by distinguishing self from non-self DNA through methylation patterns. These systems consist of a restriction endonuclease that cleaves unmethylated foreign DNA at specific recognition sequences and a cognate methyltransferase that protects the host genome by modifying the same sites. For instance, Type II RM systems, the most common variant, recognize short palindromic sequences (typically 4-8 base pairs) and exhibit high specificity, effectively degrading incoming phage DNA while sparing the methylated bacterial chromosome. This mechanism provides robust protection against a broad range of invaders, with studies showing that RM-equipped bacteria exhibit up to 1000-fold reduced phage infection rates compared to RM-deficient strains. RM systems are ubiquitous, present in over 90% of sequenced bacterial genomes, underscoring their role as a foundational innate immune analog. The CRISPR-Cas system, while often classified as adaptive due to its ability to acquire new spacer sequences from invaders for heritable memory, operates with innate-like features in its rapid spacer acquisition and phases against phages. Upon phage , the Cas1-Cas2 integrase complex captures short DNA fragments (spacers) from the invader and incorporates them into the CRISPR array adjacent to the host , enabling sequence-specific cleavage of matching foreign nucleic acids by Cas nucleases in subsequent encounters. This is innate in its germline transmission and non-clonal specificity, providing population-level resistance without requiring individual learning. Seminal work demonstrated that CRISPR confers resistance to specific phages in , with efficiency dependent on spacer-protospacer matching and PAM () sequences. Although adaptive in acquisition, the system's core mechanism mirrors innate , targeting conserved phage motifs across diverse viral populations. Toxin-antitoxin modules contribute to prokaryotic innate through abortive strategies that sacrifice the infected to prevent phage within the population. These modules encode a stable protein, which inhibits essential cellular processes such as , , or ATP synthesis, and a labile that neutralizes the under normal conditions. Upon phage detection—often via phage-induced stress or direct sensing—the is degraded, activating the and halting or inducing , thereby aborting the phage lifecycle. For example, the MazEF TA system in triggers mRNA cleavage, inhibiting protein synthesis and halting or inducing , thereby significantly reducing phage yields in infected populations. TA systems are highly prevalent, with hundreds of modules per in some , and their role in phage has been confirmed across diverse phages, emphasizing their altruistic innate at the clonal level. Quorum sensing complements these molecular defenses by enabling population-level coordination of innate responses against invaders, particularly through density-dependent signaling that activates collective behaviors like formation or release. In this process, produce and detect autoinducer molecules (e.g., acyl-homoserine lactones in Gram-negatives) that accumulate at high cell densities, triggering for defense pathways. For instance, in , regulates the expression of type VI secretion systems that deliver antibacterial effectors to neighboring cells, indirectly limiting phage spread by reducing susceptible hosts. This mechanism enhances innate resilience, as demonstrated in where inhibits lambda adsorption by modulating outer membrane porins, decreasing infection efficiency by approximately 2-fold in dense populations. By integrating individual defenses into communal strategies, ensures scalable protection without requiring genetic adaptation.

In Invertebrates

Invertebrates, lacking an , rely entirely on innate immunity for defense against , encompassing both cellular and humoral components that provide rapid, non-specific responses. Cellular immunity involves specialized hemocytes circulating in the , while humoral responses include soluble factors such as and proteolytic enzymes that target invaders systemically. These mechanisms are evolutionarily conserved across arthropods, mollusks, and other groups, enabling effective pathogen clearance without immunological . Hemocytes serve as the primary effectors of cellular immunity in and other arthropods, functioning as mobile and orchestrators of encapsulation against larger threats. In species like , plasmatocytes constitute the majority of hemocytes and mediate by engulfing bacteria and small parasites through recognition via receptors, internalizing them into phagosomes for degradation via lysosomal enzymes. Encapsulation occurs when hemocytes, including lamellocytes, aggregate around larger intruders such as eggs or nematodes, forming multilayered sheaths that often incorporate melanization to immobilize and starve the ; this process is particularly prominent in mosquitoes like , where it limits parasite development. Crystal cells, another hemocyte subtype, contribute by releasing prophenoloxidase for localized melanization during encapsulation. Humoral immunity in invertebrates features inducible antimicrobial peptides (AMPs) that disrupt microbial membranes and inhibit intracellular processes, with the Toll pathway acting as a key signaling cascade analogous to pattern recognition receptors in vertebrates. In insects such as the Cecropia silk moth (Hyalophora cecropia), injection of bacteria triggers the production of cecropins—cationic, α-helical peptides highly effective against —via Toll receptor activation by peptidoglycan recognition proteins, leading to nuclear translocation of NF-κB homologs like or Dif for AMP gene transcription. This pathway responds primarily to and fungi, inducing systemic AMP release within hours of infection, as demonstrated in Drosophila where Toll mutants exhibit heightened susceptibility. Proteolytic cascades underpin additional humoral defenses, notably the prophenoloxidase (proPO) system, which promotes melanization for killing and clotting for sealing in arthropods. Activation begins with proteins binding microbial surfaces, initiating a that cleaves proPO zymogens into active phenoloxidase, which oxidizes to quinones and ultimately ; this encases pathogens in a toxic, hardened barrier, as seen in (Pacifastacus leniusculus) where proPO limits fungal growth. In clotting, the cross-links proteins like vitellogenin homologs to form a fibrin-like mesh that prevents loss and sequesters invaders, regulated by serpins to avoid excessive activation; for instance, in the tobacco hornworm (Manduca sexta), proteinases HP6 and HP8 drive proPO-mediated clotting at injury sites. While effective, the proPO system's costs and potential for evasion highlight its context-dependent role. Invertebrates also employ RNA interference (RNAi) as a sequence-specific antiviral mechanism, where Dicer enzymes process viral double-stranded RNA into small interfering RNAs that guide Argonaute-mediated degradation of viral genomes. In insects like Drosophila melanogaster, Dicer-2 cleaves viral replication intermediates into 21-nucleotide siRNAs, suppressing RNA virus replication; mutants lacking Dicer-2 show dramatically increased viral loads from pathogens such as flock house virus. This pathway operates independently of other innate arms, providing targeted defense against diverse viruses in mosquitoes (Anopheles gambiae) and other invertebrates, with evidence from dsRNA injection experiments confirming its intrinsic role in limiting infection spread.

In Plants

Plants possess a sophisticated innate immune system adapted to their sessile lifestyle, relying on cell-autonomous defenses without specialized immune cells or adaptive responses. This system primarily operates through two interconnected layers: pattern-triggered immunity (PTI) and effector-triggered immunity (ETI), which detect microbial invaders and deploy localized and systemic defenses. PTI involves surface-localized receptors (PRRs) that sense conserved microbial features, while ETI employs intracellular nucleotide-binding (NLR) receptors to detect effectors. These mechanisms share evolutionary parallels with animal PRRs, reflecting ancient conserved pathways for microbial detection. Pattern-triggered immunity (PTI) forms the basal defense layer in , where PRRs such as FLAGELLIN-SENSING 2 (FLS2), a receptor , perceive bacterial epitopes like flg22, initiating rapid signaling cascades. Upon binding, FLS2 associates with co-receptors like BAK1, activating (MAPK) pathways and leading to a burst of (ROS) production via NADPH oxidases, which reinforces cell walls and restricts spread. This response also induces expression of defense genes encoding antimicrobial compounds, providing broad-spectrum resistance against non-adapted microbes. Effector-triggered immunity (ETI) acts as a specialized counter to PTI-suppressing effectors secreted by adapted pathogens, mediated by NLR proteins that recognize specific avirulence factors inside host cells. NLR activation, often through conformational changes in their nucleotide-binding and domains, triggers a robust (HR), characterized by localized at sites to contain pathogens. This amplifies PTI signals, including elevated ROS and hormone accumulation, conferring race-specific resistance. Seminal studies have established the gene-for-gene model underlying NLR-effector interactions, highlighting ETI's role in halting virulent invasions. Systemic acquired resistance (SAR) enables long-distance priming of defenses following local infections, primarily orchestrated by (SA) signaling that mobilizes from primary sites to distal tissues. SA accumulation, derived from isochorismate or pathways, activates non-expressor of genes 1 (NPR1), a key regulator that translocates to the to induce pathogenesis-related () proteins with activity. This establishes a heightened state of readiness, enhancing PTI and ETI responses plant-wide for weeks, as demonstrated in foundational models of induced resistance. An additional antiviral arm of plant innate immunity involves RNA silencing, where double-stranded viral RNAs are processed into small interfering RNAs (siRNAs) by Dicer-like enzymes, which then guide proteins in the (RISC) to degrade complementary viral genomes. This pathway targets and DNA viruses alike, preventing replication and spread through sequence-specific cleavage. -mediated silencing exemplifies plants' RNA-based defenses, evolved to counter viral counter-suppressors that inhibit this mechanism.

References

  1. [1]
    Innate immune system - Autoimmunity - NCBI Bookshelf - NIH
    Innate immunity is the host's first line of defense and is intended to prevent infection and attack the invading pathogens.This nonspecific mechanism is fast ( ...Introduction · Components of the innate... · Characteristics of the innate...
  2. [2]
    Innate Immunity - Molecular Biology of the Cell - NCBI Bookshelf - NIH
    The innate immune responses are the first line of defense against invading pathogens. They are also required to initiate specific adaptive immune responses.Human Cells Recognize... · Phagocytic Cells Seek, Engulf...
  3. [3]
    Overview of the Immune Response - PMC - PubMed Central
    Broadly defined, the innate immune system includes all aspects of the host's immune defense mechanisms that are encoded in their mature functional forms by the ...
  4. [4]
    Innate and Adaptive Immune Memory: an Evolutionary Continuum in ...
    Jan 9, 2019 · During an infection, the innate immunity is the first to be triggered (the inflammatory reaction), taking no longer than minutes to hours to be ...
  5. [5]
    PAMPs and DAMPs: signal 0s that spur autophagy and immunity
    Pathogen-associated molecular pattern molecules (PAMPs) are derived from microorganisms and recognized by pattern recognition receptor (PRR)-bearing cells ...
  6. [6]
    An introduction to immunology and immunopathology
    Sep 12, 2018 · It is a rapid immune response, initiated within minutes or hours after aggression, that has no immunologic memory. Adaptive immunity, on the ...The Immune System: Innate... · Innate Immunity · Adaptive ImmunityMissing: speed | Show results with:speed
  7. [7]
    The Immune System in Tissue Environments Regaining ...
    The inflammatory mediators of the innate immune system are important regulators of tissue homeostasis. They modulate tissue environments at all phases of the ...
  8. [8]
    Chapter 2: Innate Immunity - PMC - PubMed Central
    Innate immunity, an evolutionarily ancient component of host defense, is present in all multicellular organisms while adaptive immunity evolved much later and ...
  9. [9]
    Centennial of Metchnikoff's discovery - PubMed
    Phagocytosis was discovered by Elie Metchnikoff (Ilia Mechnikov) in 1882. Although the phenomenon of endocytosis by the leukocytes (more related to the ...<|separator|>
  10. [10]
    In brief: The innate and adaptive immune systems - NCBI - NIH
    Aug 14, 2023 · The innate immune system is the body's first line of defense against intruders. It responds in the same way to all germs and foreign substances.The innate immune system... · Protection offered by immune... · cells
  11. [11]
    Innate and adaptive immunity: specificities and signaling hierarchies ...
    In general, innate immunity is considered a nonspecific response, whereas the adaptive immune system is thought of as being very specific.
  12. [12]
    Anatomical Barrier - an overview | ScienceDirect Topics
    Anatomical barriers are defined as physical structures, such as the skin and mucous membranes, that impede the entry of microorganisms and protect the body ...<|control11|><|separator|>
  13. [13]
    Epithelial antimicrobial peptides in host defense against infection - NIH
    Antimicrobial peptides, including defensins, cathelicidins and histatins, have a broad spectrum of activity against Gram-positive and Gram-negative bacteria as ...
  14. [14]
    Human antimicrobial peptides: defensins, cathelicidins and histatins
    In this review we discuss three important groups of human antimicrobial peptides. The defensins are cationic non-glycosylated peptides containing six cysteine ...
  15. [15]
    Cathelicidins: family of antimicrobial peptides. A review - PMC - NIH
    These proteolytically activated peptides are part of the innate immune system of many vertebrates. These peptides show a broad spectrum of antimicrobial ...
  16. [16]
    From bacterial killing to immune modulation: Recent insights into the ...
    Sep 21, 2017 · Lysozyme is a cornerstone of innate immunity. The canonical mechanism for bacterial killing by lysozyme occurs through the hydrolysis of cell wall ...
  17. [17]
    Lactoferrin, the Moonlighting Protein of Innate Immunity - PMC
    Nov 2, 2023 · Lactoferrin (Lf), a naturally occurring glycoprotein involved in innate immunity, was first discovered in bovine milk [1] and later purified ...
  18. [18]
    Mammalian Gut Immunity - PMC - PubMed Central - NIH
    Further, the physical barrier is well supported by a delicate balance of chemical barriers such as acidity (low pH), detergents (bile salts), proteolytic ...
  19. [19]
    Interactions between Bacteria and Bile Salts in the Gastrointestinal ...
    Oct 3, 2017 · Bile salts and bacteria have intricate relationships. The composition of the intestinal pool of bile salts is shaped by bacterial metabolism.
  20. [20]
    Immunodeficiency and Mucosal Immunity - PMC - PubMed Central
    Secretory IgA (S-IgA) binds commensal flora and other intestinal antigens and is considered an important part of the T-cell-independent mucosal immune system.
  21. [21]
    Phagocytosis: A Fundamental Process in Immunity - PMC
    Phagocytosis is an elegant but complex process for the ingestion and elimination of pathogens, but it is also important for the elimination of apoptotic cells.
  22. [22]
    Diversity and Versatility of Phagocytosis: Roles in Innate Immunity ...
    May 23, 2017 · Professional phagocytes play a central role in innate immunity by eliminating pathogenic bacteria, fungi and malignant cells, and contribute to adaptive ...Phagocytosis Of Microbes · Phagocytosis Of Tumor Cells · Antigen Presentation
  23. [23]
    Innate Immunity and its Regulation by Mast Cells - PMC
    Stimuli such as many whole bacteria, parasite products, and even the structure of certain viruses can induce release of a MC's cytoplasmic granules. At a site ...
  24. [24]
    γδ T cells: origin and fate, subsets, diseases and immunotherapy
    Nov 22, 2023 · In this comprehensive review, we explore the origin and fate of γδ T cells, their subsets, their relevance to various diseases including infections, autoimmune ...
  25. [25]
    IgE and mast cells in host defense against parasites and venoms - NIH
    Data from epidemiological studies suggest a protective role of IgE antibodies in infections with certain parasites in humans, as the levels of parasite-specific ...
  26. [26]
    Harnessing the Power of Mast Cells in unconventional ... - NIH
    Aside from their role in allergies, mast cells are probably best known for controlling parasite infections. Through multiple mechanisms, both independent of IgE ...
  27. [27]
    Basophils and Eosinophils in Nematode Infections - PMC - NIH
    In this review, we summarize the latest research on the pivotal and nonredundant roles of basophils and eosinophils in nematode infection.
  28. [28]
    Physiology, Major Basic Protein - StatPearls - NCBI Bookshelf - NIH
    Jul 25, 2023 · Major basic protein (MBP) is an eosinophil granule protein. Eosinophil granules contain a crystalloid core comprised of MBP and a matrix consisting of other ...
  29. [29]
    Eosinophils in helminth infection: defenders and dupes - PMC
    Eosinophilia is a central feature of the host response to helminth infection. Larval stages of parasitic worms are killed in vitro by eosinophils.
  30. [30]
    NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in ... - NIH
    Both the uptake of perforin and granzymes by target cells and TNF family death receptor signaling cause target cell apoptosis (29), while IFNγ released by NK ...
  31. [31]
    Natural killer cells in antiviral immunity | Nature Reviews Immunology
    Jun 11, 2021 · Natural killer (NK) cells play an important role in innate immune responses to viral infections. Here, we review recent insights into the role of NK cells in ...
  32. [32]
    Contribution of natural killer cells in innate immunity against ... - NIH
    Natural killer cells are members of the innate immune system and promote cytotoxic activity against tumor or infected cells independently from MHC recognition.
  33. [33]
    The distinct MHC-unrestricted immunobiology of innate-like and ...
    Oct 21, 2020 · Human γδ T cells have innate-like and adaptive-like immunobiology, using unique recognition via non-MHC proteins, and can act as multimolecular ...
  34. [34]
    Pattern recognition receptors in health and diseases - Nature
    Aug 4, 2021 · PAMPs are essential for pathogen survival and usually have unique molecular or subcellular characteristics that are not found in host cells.
  35. [35]
  36. [36]
    The complement system and innate immunity - Immunobiology - NCBI
    The complement system is one of the major mechanisms by which pathogen recognition is converted into an effective host defense against initial infection.2-5. Complement is a system... · 2-9. Hydrolysis of C3 causes...
  37. [37]
    The complement system - PMC - NIH
    The complement system consists of a tightly regulated network of proteins that play an important role in host defense and inflammation.
  38. [38]
    Inflammation–Nature's Way to Efficiently Respond to All Types of ...
    ... immune system. Cytokines critical to the effectiveness of the innate immune system include IL-1, IL-6, tumor necrosis factor-alpha (TNF-α), and IFN-α. These ...
  39. [39]
    Cytokines, Chemokines and Their Receptors - NCBI - NIH
    IL-1α and IL-1βare produced mainly by mononuclear and epithelial cells upon inflammation, injury and infection. These two proteins are of primary importance to ...Cytokines, Chemokines And... · Il-1-Like Cytokines · Chemokines, Their Receptors...
  40. [40]
    Cytokines in Inflammatory Disease - PMC - PubMed Central
    In this review, we focus on the existing literature dealing with the biology of cytokines interleukin (IL)-6, IL-1, IL-33, tumor necrosis factor-alpha (TNF-α), ...2. Cytokines · Table 1 · 2.2. Interleukin 1 Family
  41. [41]
    The chemokines CXCL8 and CXCL12: molecular and functional ...
    Feb 1, 2023 · CXCL8 is the most potent human neutrophil-attracting chemokine and plays crucial roles in the response to infection and tissue injury.
  42. [42]
    The Chemokine System in Innate Immunity - PMC - PubMed Central
    In addition to producing chemokines, resident innate immune cells also produce inflammatory cytokines, such as tumor necrosis factor (TNF) and IL-1. These ...Chemokines And Chemokine... · Table 1 · Entry Of Blood-Borne Cells...
  43. [43]
    Humoral Innate Immunity and Acute-Phase Proteins - PMC
    Feb 2, 2023 · C-reactive protein (also called PTX1) and serum amyloid P component (SAP, or PTX2) are pentameric short pentraxins. PTX3 is an octameric ...
  44. [44]
    Serum amyloid P component and C-reactive protein ... - PubMed - NIH
    Jan 15, 2001 · The pentraxins, serum amyloid P component (SAP) and C-reactive protein (CRP) are acute-phase serum proteins in mice and humans, respectively.
  45. [45]
    The role of anaphylatoxins C3a and C5a in regulating ... - PubMed
    C3a and C5a, the small (approximately 10KDa) cleavage fragments released by complement activation, are potent mediators of inflammation. They are anaphylatoxins ...
  46. [46]
    Role of Histamine in Modulating the Immune Response and ...
    3. Histamine Stimulates Inflammation. Inflammatory mediators are molecules produced by activated cells that intensify and prolong the inflammatory response.
  47. [47]
    The crucial roles of inflammatory mediators in inflammation: A review
    A variety of chemical mediators from circulation system, inflammatory cells, and injured tissue actively contribute to and adjust the inflammatory response [24] ...
  48. [48]
    Acute Inflammatory Response - StatPearls - NCBI Bookshelf - NIH
    Acute inflammation is an immediate, adaptive response with limited specificity caused by noxious stimuli, such as infection and tissue damage.Missing: vasoactive | Show results with:vasoactive
  49. [49]
    Role of Interleukin 10 Transcriptional Regulation in Inflammation ...
    Interleukin 10 is an anti-inflammatory cytokine that plays a crucial role in preventing inflammatory and autoimmune pathologies. Elevated levels of IL-10 can ...
  50. [50]
    The multifaceted nature of IL-10: regulation, role in immunological ...
    During acute infections, IL-10 limits the magnitude of the immune responses, preventing excessive inflammation and protecting tissues from immune-mediated ...
  51. [51]
    IL-10: A Multifunctional Cytokine in Viral Infections - PubMed Central
    The anti-inflammatory master regulator IL-10 is critical to protect the host from tissue damage during acute phases of immune responses.
  52. [52]
    Physiology and immunology of the cholinergic antiinflammatory ... - JCI
    Feb 1, 2007 · The nervous system, via an inflammatory reflex of the vagus nerve, can inhibit cytokine release and thereby prevent tissue injury and death.Missing: paper | Show results with:paper
  53. [53]
    Pleiotropic Effects of Glucocorticoids on the Immune System in ...
    Taken together, endogenous GCs suppress excessive inflammation and cell-mediated immunity via innate and cytotoxic immune cells. The Circadian Rhythm of T ...
  54. [54]
    Adrenergic regulation of innate immunity: a review - Frontiers
    In human neutrophils, adrenaline and noradrenaline inhibit migration, CD11b/CD18 expression, and oxidative metabolism, possibly through β-AR, although the role ...Abstract · Introduction · The Innate Immune System · Adrenergic Modulation of the...
  55. [55]
    Neuro-immune crosstalk and allergic inflammation - JCI
    Mar 4, 2019 · Sensory nerve–derived substance P induces mast cell degranulation and release of histamine, TNF-α, leukotriene B4, and vascular endothelial ...
  56. [56]
    Insights into Soluble Toll-Like Receptor 2 as a Downregulator ... - NIH
    Aug 2, 2016 · Recent findings indicate a parallel pathway by which responses to both viral and bacterial infections is controlled via the secretion of soluble TLR2 (sTLR2).
  57. [57]
    A20: Central Gatekeeper in Inflammation and Immunity - ScienceDirect
    A20 is an early NF-κB-responsive gene that encodes a ubiquitin-editing protein that is involved in the negative feedback regulation of NF-κB signaling.
  58. [58]
    The Immunobiology of TLR4 Agonists: From Endotoxin Tolerance to ...
    Endotoxin tolerance is characterized by attenuated production of pro-inflammatory cytokines such as TNFα, IL-6 and interferon (IFN) γ, and increased production ...
  59. [59]
    Apoptotic cell clearance: basic biology and therapeutic potential - PMC
    The detection and disposal of apoptotic cells generally promote an anti-inflammatory response at the tissue level, as well as immunological tolerance.
  60. [60]
    Interaction between microbiota and immunity in health and disease
    May 20, 2020 · A remarkable feature of the intestinal immune system is its ability to establish immune tolerance towards an enormous and constantly changing ...
  61. [61]
    Role of the Microbiota in Immunity and inflammation - PMC
    The microbiota plays a fundamental role on the induction, training and function of the host immune system.
  62. [62]
  63. [63]
    Bacterial Capsules and Evasion of Immune Responses | Request PDF
    Bacterial capsules are generally thought to contribute to evasion of host defenses by cloaking immunostimulatory structures present on the bacterial surface.
  64. [64]
    Molecular mimicry of host sialylated glycans allows a bacterial ...
    Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response Available. Brief ...
  65. [65]
    Protease-dependent mechanisms of complement evasion by ...
    In this review, we focus on those bacteria that deploy proteases capable of degrading complement system components into non-functional fragments.
  66. [66]
    The clinical impact of bacterial biofilms - Nature
    Apr 1, 2011 · Bacterial biofilms are resistant to antibiotics, disinfectant chemicals and to phagocytosis and other components of the innate and adaptive inflammatory ...
  67. [67]
    How Biofilms Evade Host Defenses | Microbiology Spectrum
    It seems that biofilm matrix can protect bacteria from antibody-mediated phagocytosis (62). Another mechanism utilized by S. aureus biofilms to evade host ...
  68. [68]
    Bacterial strategies for overcoming host innate and adaptive ...
    Nov 1, 2002 · Alternatively, the secretion of bacterial toxins impairs protective functions and facilitates colonization. For example, Bordetella ...
  69. [69]
    Salmonella Virulence and Immune Escape - PMC - PubMed Central
    Lysosomes in phagocytic cells contain a variety of hydrolases for combating bacteria. Evading lysozyme degradation is an important strategy for the survival of ...
  70. [70]
    Salmonella evasion of the NADPH phagocyte oxidase - ScienceDirect
    We review both well-known and recently discovered mechanisms that help Salmonella to evade potentially lethal effects of the NADPH phagocyte oxidase.
  71. [71]
    How Pathogens Target and Subvert the Host Innate Immune System
    In either case however, YopK targets and cloaks a newly recognized PAMP, highlighting the evolutionary arms race that takes place between host and pathogen.
  72. [72]
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon ... - NIH
    Mapping studies suggest that NSP1 prevents IFN induction in part by blocking IRF3 phosphorylation. In addition, NSP1-induced depletion of Tyk2 and STAT2 ...
  73. [73]
    Human Immunodeficiency Virus Type 1 Tat Protein Inhibits the ...
    Because acetylated p65 is more active as a transcription factor, Tat hyperactivates the expression of NF-κB-responsive genes, a function lost in SIRT1−/− cells.
  74. [74]
    E1B 19K Inhibits Fas-mediated Apoptosis through FADD-dependent ...
    E1B 19K, the adenovirus Bcl-2 homologue, is a potent inhibitor of apoptosis induced by various stimuli including Fas and tumor necrosis factor-α.
  75. [75]
    Modulation of Innate Immune Signaling Pathways by Herpesviruses
    These signaling events constitute host innate immunity to defeat herpesvirus infection and replication. A hallmark of all herpesviruses is their ability to ...
  76. [76]
    SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune ...
    Our studies reveal that SARS-CoV-2 Delta has integrated multiple mechanisms to silence the host innate immune response and evade the IFN response.Missing: post- | Show results with:post-
  77. [77]
    TLRs in COVID-19: How they drive immunopathology and the ...
    TLRs are germline encoded PRRs that are believed to be important for both the protective and maladaptive response to lower respiratory viral infection.Missing: post- | Show results with:post-
  78. [78]
    The coordination of anti-phage immunity mechanisms in bacterial cells
    Dec 1, 2022 · Among the most common anti-phage defenses are the restriction-modification (RM) systems that detect and attack foreign DNA in the cytoplasm of ...
  79. [79]
    Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria
    Nov 23, 2020 · Abstract. Prokaryotes have developed numerous defense strategies to combat the constant threat posed by the diverse genetic parasites that ...Missing: paper | Show results with:paper
  80. [80]
    The CRISPR-Cas immune system: Biology, mechanisms and ...
    CRISPR-Cas, the adaptive and heritable immune system of prokaryotes is described. Biological and mechanistic aspects as well as applied use are covered.
  81. [81]
    A Primary Physiological Role of Toxin/Antitoxin Systems Is Phage ...
    Aug 12, 2020 · Critically, to thwart bacterial phage inhibition systems, phages now have been identified that include antitoxins in their genome to inhibit ...
  82. [82]
    A Quorum-Sensing-Induced Bacteriophage Defense Mechanism
    This proof-of-principle study shows that quorum sensing plays an important role in determining the susceptibility of E. coli to infection by bacteriophages λ ...
  83. [83]
    Quorum Sensing Controls Adaptive Immunity through the ... - NIH
    Nov 17, 2016 · In this study, we demonstrate that QS regulation results in increased expression of the type IE, IF, and III-A CRISPR-Cas systems in Serratia cells in high- ...Results · Figure 2 · Discussion
  84. [84]
    Invertebrate immunity and the limits of mechanistic immunology
    Jun 21, 2005 · The invertebrate innate immune system comprises cellular responses (phagocytes and so on), a variety of inducible antibacterial peptides and a ...Missing: review | Show results with:review
  85. [85]
  86. [86]
    Discovery of Plasmodium modulators by genome-wide ... - PNAS
    Insect hemocytes mediate important cellular immune responses including phagocytosis and encapsulation and also secrete immune factors such as opsonins ...Results · Rnai Screen To Identify New... · Mosquito Rearing And P...
  87. [87]
  88. [88]
  89. [89]
  90. [90]
    Is RNA interference involved in intrinsic antiviral immunity in ... - Nature
    May 19, 2006 · It is now apparent that invertebrates, and more specifically nematodes and insects, also use RNAi to help control viral infections. Flock house ...
  91. [91]
    Molecular mechanisms of early plant pattern-triggered immune ...
    Sep 2, 2021 · Here, we discuss the critical roles of PRR complex formation and phosphorylation in activating PTI signaling, as well as the emerging paradigm.
  92. [92]
    The plant hypersensitive response: concepts, control and ...
    Jul 15, 2019 · The hypersensitive defence response is found in all higher plants and is characterized by a rapid cell death at the point of pathogen ingress.
  93. [93]
    RNA silencing in plants - Nature
    Sep 15, 2004 · In a wild-type plant (a) an miRNA associated with RISC will base pair to its cognate target and promote either sequence-specific RNA degradation ...
  94. [94]
    ARGONAUTE2 mediates RNA-silencing antiviral defenses against ...
    RNA-silencing mechanisms control many aspects of gene regulation including the detection and degradation of viral RNA through the action of, among others ...